Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Citius Oncology
Citius Oncology
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Citius Oncology
Stock Price
$1.2
2024-10-29
Market Capitalization
$86.6 M
2024-10-29
Citius Oncology Summary
Company Summary
Overview
Citius Oncology is a company that operates a platform to develop and commercialize novel targeted oncology therapies.
Type
Public
Status
Active
Founded
2021
HQ
New York, NY, US
|
view all locations
Sectors
Healthcare
clinical research
drug development
oncology
Table of Contents
Key People
Locations
Financials
Key People
Xiaofeng Yuan,
Chief Executive Officer and Chairman
Locations
View all
1 location detected
New York, NY
HQ
United States
420 Lexington Ave #2446
Citius Oncology Financials
Summary Financials
Revenue (Q2, 2026)
$1.7M
Gross profit (Q2, 2026)
$1.3M
Net income (Q2, 2026)
($26.6M)
Cash (Q2, 2026)
$2.6M
EBIT (Q2, 2026)
($28.6M)
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top